PharmaJet and Mundipharma have inked an exclusive partnership to market and distribute PharmaJet’s Tropis and Stratis needle-free drug-delivery devices to more than 120 markets around the world.
The devices are designed for vaccine immunizations. PharmaJet, which has an ongoing deal to use its devices in the World Health Organization’s efforts to eradicate polio, touts that the Tropis device enables mass-scale fractional dose poliovirus vaccine dosing at a lower total cost compared to intramuscular injections.
Get the full story at our sister site, Drug Delivery Business News.
The post PharmaJet, Mundipharma team up to boost access to needle-free drug-delivery systems appeared first on MassDevice.
from MassDevice https://ift.tt/2OhDHEd
Cap comentari:
Publica un comentari a l'entrada